• Cancel
    Date：2026-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=944

    SIYOMICRO today announced that it has raised RMB 100 million-level financing. The round was led by a leading strategic industrial investor, with participation from Goldport Capital and Longgang Guiding Fund. The proceeds from this financing will be prima

  • Cancel
    Date：2026-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=941

    SynMetabio today announced that it has raised over RMB 100 million in its Series A financing round.This round was jointly led by Erdos Group and Heda Jinfu, with participation from Nest Bio. CEC Capital acted as the sole financial advisor to SynMetabio i

  • Cancel
    Date：2026-03

    Chief Financial Advisor to NRT

  • Cancel
    Date：2026-03
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=927

    Recently, IRIS, a world-leading contact lens R&D and manufacturing platform, announced it has raised several hundred million RMB in Series B+ Financing. This round of financing was exclusively led by Cenova Capital, a well-known investment institution. C

  • Cancel
    Date：2026-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=921

    Recently, CAStar Foods, a leader in China’s biosynthetic human-derived bioactive protein industry, announced the closing of a Series A+ financing round worth several hundred million RMB. The company’s independently developed A60 bioactive peptide replicates rare core protein fragments found in breast milk, boasting immense potential in the fields of nutritional immunology and health. Proceeds from this financing round will be mainly allocated to advancing the industrialization of the company’s core functional protein/peptide products and their global market expansion. CEC Capital acted as the exclusive financial advisor to CAStar Foods for this transaction.

  • Cancel
    Date：2026-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=919

    Recently, MicroCyto announced the closing of a new round of equity financing worth nearly 300 million RMB. The investors include Beijing New Materials Industry Investment Fund, Beijing Medical and Health Industry Investment Fund, Zhongguancun Capital, and

  • Cancel
    Date：2025-12
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=917

    Refine Biology recently announced the closing of a several hundred million RMB Series C financing round. The round was led by Xingxiang Asset Management Group, with participation from Royal Power XMXYG Fund as a co-investor. Proceeds from this financing w

  • Cancel
    Date：2025-09
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=908

    iRegene, a biotech company committed to becoming a global leader in universal chemically induced cell therapies, recently announced the successful completion of its Series B+ financing round. The round was jointly led by Northern Light Venture Capital, Ch

  • Cancel
    Date：2025-04

    Exclusive Financial Advisor to IREGENE